| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
185,000,000 |
| Market
Cap: |
18.67(B) |
| Last
Volume: |
19,380,244 |
Avg
Vol: |
2,183,587 |
| 52
Week Range: |
$40.31 - $100.67 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 64 |
| Guru Rank Value : 12.4 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Exact Sciences is a cancer screening and diagnostics company. Co.'s primary screening product, the Cologuard® test, is a non-invasive stool-based DNA screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Co.'s portfolio of Oncotype tests include: Oncotype DX gene expression tests for breast, prostate and colon cancers; Oncotype DX AR-V7 Nucleus Detect® test, a liquid-based test for advanced stage prostate cancer; and Oncotype MAP™ Pan-Cancer Tissue test (oncomap test), a test delivering tumor profiling to aid therapy selection for patients with metastatic, refractory or recurrent cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
19,500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$1,001,325 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
19,858 |
24,550 |
24,550 |
134,806 |
| Total Sell Value |
$1,295,409 |
$1,528,421 |
$1,528,421 |
$8,229,391 |
| Total People Sold |
4 |
4 |
4 |
11 |
| Total Sell Transactions |
5 |
7 |
7 |
61 |
| End Date |
2025-08-24 |
2025-05-23 |
2024-11-22 |
2023-11-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Herriott James |
SVP, General Counsel & Sec |
• – – |
2025-11-04 |
4 |
AS |
$70.08 |
$105,120 |
D/D |
(1,500) |
12,585 |
|
45% |
|
| Baranick Brian |
EVP, GM, Precision Oncology |
• – – |
2025-11-04 |
4 |
AS |
$70.08 |
$200,289 |
D/D |
(2,858) |
22,368 |
|
45% |
|
| Napier Katherine S |
|
– • – |
2025-10-24 |
4 |
AS |
$65.00 |
$780,000 |
D/D |
(12,000) |
60,759 |
|
56% |
|
| Doyle James Edward |
|
– • – |
2025-10-09 |
4 |
AS |
$60.00 |
$120,000 |
D/D |
(2,000) |
57,962 |
|
70% |
|
| Herriott James |
SVP, General Counsel & Sec |
• – – |
2025-10-09 |
4 |
AS |
$60.00 |
$90,000 |
D/D |
(1,500) |
14,085 |
|
70% |
|
| Doyle James Edward |
|
– • – |
2025-08-13 |
4 |
AS |
$42.02 |
$62,400 |
D/D |
(1,485) |
59,962 |
|
125% |
|
| Baranick Brian |
EVP, GM, Precision Oncology |
• – – |
2025-08-05 |
4 |
D |
$46.83 |
$127,237 |
D/D |
(2,717) |
25,226 |
|
- |
|
| Baranick Brian |
EVP, GM, Precision Oncology |
• – – |
2025-08-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,350 |
27,943 |
|
- |
|
| Orville Jacob A |
EVP, GM, Screening |
• – – |
2025-08-05 |
4 |
D |
$46.83 |
$117,777 |
D/D |
(2,515) |
28,237 |
|
- |
|
| Orville Jacob A |
EVP, GM, Screening |
• – – |
2025-08-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,350 |
30,752 |
|
- |
|
| Napier Katherine S |
|
– • – |
2025-06-13 |
4 |
AS |
$53.20 |
$170,612 |
D/D |
(3,207) |
72,759 |
|
18% |
|
| Clancy Paul J |
|
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,398 |
26,038 |
|
- |
|
| Trigg Leslie |
|
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,670 |
17,169 |
|
- |
|
| Barber Michael J |
|
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,197 |
13,136 |
|
- |
|
| Doyle James Edward |
|
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,398 |
61,447 |
|
- |
|
| Coward D Scott |
|
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,398 |
57,562 |
|
- |
|
| Levangie Daniel J |
|
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,398 |
34,312 |
|
- |
|
| Napier Katherine S |
|
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,398 |
75,966 |
|
- |
|
| Petrovic Shacey |
|
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
5,398 |
21,804 |
|
- |
|
| Popovits Kimberly J |
|
– • – |
2025-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,994 |
16,381 |
|
- |
|
| Herriott James |
SVP, General Counsel & Sec |
• – – |
2025-04-30 |
4 |
A |
$38.26 |
$13,888 |
D/D |
363 |
15,585 |
|
- |
|
| Trigg Leslie |
|
– • – |
2025-04-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
972 |
|
20% |
|
| Trigg Leslie |
|
– • – |
2025-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
8,527 |
9,499 |
|
- |
|
| Bloomer Aaron |
EVP, Chief Financial Officer |
• – – |
2025-04-15 |
4 |
D |
$44.25 |
$479,537 |
D/D |
(10,837) |
13,623 |
|
- |
|
| Bloomer Aaron |
EVP, Chief Financial Officer |
• – – |
2025-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,460 |
19,340 |
|
- |
|
791 Records found
|
|
Page 1 of 32 |
|
|
0.23 (0.23%) 
